Huntington's disease: underlying molecular mechanisms and emerging concepts

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder with no current disease-modifying treatments.
• Shared molecular and cellular pathologies exist between HD and other neurological disorders, indicating common underlying mechanisms.
• Recent research has improved understanding of cellular regulation and responses to expanded polyglutamine proteins, like mutant huntingtin.

Purpose of the Study:

• To summarize key pathways and networks critical to Huntington's disease.
• To review recent therapeutic advances relevant to these pathways.
• To explore the relevance of these interconnected pathways to other protein-folding disorders.

Main Methods:

• Literature review and synthesis of recent findings on Huntington's disease molecular and cellular mechanisms.
• Analysis of cellular responses to expanded polyglutamine proteins, including transcriptional regulation.
• Examination of therapeutic strategies targeting identified pathways.

Main Results:

• Cells regulate and respond to expanded polyglutamine proteins through mechanisms affecting folding, aggregation, and clearance.
• A general transcriptional mechanism significantly influences the expression of polyglutamine proteins.
• Interplay between these pathways is crucial for disease progression and offers therapeutic targets.

Conclusions:

• Understanding the transcriptional and protein-regulatory mechanisms in HD is vital for developing new treatments.
• The identified pathways and their interactions are relevant not only to Huntington's disease but also to other protein-folding disorders.
• Targeting these common pathways holds promise for future therapeutic interventions in neurodegenerative diseases.